Prof. Shimon Slavin, MD, the CTCI Medical and Scientific Director, is internationally renowned for his innovative use of cell therapy and immunotherapy in treating cancer and life-threatening non-malignant diseases.

His pioneering work in cell therapy of cancer by donor lymphocyte infusions (DLI), post allogeneic stem cell transplantation, and nonmyeloablative stem cell transplantation (NST) is now in worldwide use. NST is much safer, less difficult for the patient, and more economical than previously developed procedures.

Prof. Slavin has also developed personalized approaches to treat cancer using immunotherapy mediated by innovative targeted cell therapy and vaccines; to immune-regulate autoimmune diseases; and to induce transplantation tolerance to bone marrow and organ allografts. Prof. Slavin pioneered the use of multi-potent stem cells for regenerative medicine, focusing on down-regulation of harmful self-reactive lymphocytes and repair of damaged tissues and organs.

Prof. Slavin conducts basic clinical research and clinical trials of novel methods to make a patient's immune system effective in targeting and combating the patient's disease. The world's leading peer-reviewed journals have published over 500 articles of his research. He has authored 4 books on his medical research and innovations.

Prof. Slavin earned his MD from the Hadassah Hebrew University School of Medicine in Jerusalem, Israel. He trained in immunology and rheumatology at Stanford University in California and at the Fred Hutchinson Bone Marrow Transplantation Center in Seattle, Washington.

Prof. Harry Brenner brings over 40 years of experience in oncology and radiation therapy to the International Center for Cell Therapy & Cancer Immunotherapy. Prof. Brenner was the Director of Radiation Oncology at the Rabin Medical Center and the Medical Director for Machon Eshkol Community Medical Service in Israel. He has also served as the Director of the Institute of Radiotherapy and Oncology at Sheba Medical Center, Chairman of the Israel National Examination Board for Oncology, and Chairman of Oncology at Tel Aviv University. Prof. Brenner has served as a consulting oncologist for several of the leading hospitals in Israel.

Prof. Brenner has held numerous visiting positions in the most prestigious international medical institutions, such as Memorial Sloan-Kettering Cancer Center, Brown University, Mount Sinai Medical Center, Cornell University Medical Center, Royal College of Radiologists, and The Royal Marsden Hospital.

Throughout his career, Prof. Brenner has been granted prestigious awards for excellence in medicine. He has published over 60 articles in leading international peer-reviewed journals on a variety of topics. Prof. Brenner earned his medical degrees from the University of Cape Town, South Africa.